Backstrom Jay T. has filed 12 insider transactions across 4 companies since December 2022.
Most recent transaction: a disposition of 33390 shares of LAVA Therapeutics NV ($LVTX) on November 13, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2025 | LAVA Therapeutics NV | $LVTX | Backstrom Jay T. | Not found | D | Share Options (Right to Buy) | 33390 | $0.00 | 0.0000 | 26,899,122 | 100.00% | 0.12% |
| July 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Backstrom Jay T. | Director | A | Restricted stock units | 4341 | $0.00 | 4,341.0000 | 74,254,956,000 | 9999.99% | 0.00% |
| July 8, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Backstrom Jay T. | Director | A | Stock options (right to buy) | 23393 | $0.00 | 23,393.0000 | 74,254,956,000 | 9999.99% | 0.00% |
| March 10, 2025 | Scholar Rock Holding Corp | $SRRK | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A | Common Stock | 113570 | $0.00 | 425,561.0000 | 99,838,102 | 36.40% | 0.11% |
| March 10, 2025 | Scholar Rock Holding Corp | $SRRK | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 151430 | $0.00 | 151,430.0000 | 99,838,102 | 9999.99% | 0.15% |
| Feb. 18, 2025 | Scholar Rock Holding Corp | $SRRK | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | S | Common Stock | 18372 | $36.83 | 311,991.0000 | 99,838,102 | 5.56% | 0.02% |
| Feb. 13, 2025 | LAVA Therapeutics NV | $LVTX | Backstrom Jay T. | Not found | A | Common Shares (Right to Buy) | 33390 | $0.00 | 33,390.0000 | 26,834,422 | 9999.99% | 0.12% |
| Jan. 16, 2025 | Scholar Rock Holding Corp | $SRRK | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | S | Common Stock | 22308 | $44.20 | 330,363.0000 | 99,838,102 | 6.33% | 0.02% |
| Feb. 16, 2024 | Scholar Rock Holding Corp | $SRRK | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | S | Common Stock | 11614 | $15.74 | 352,671.0000 | 83,347,086 | 3.19% | 0.01% |
| Feb. 12, 2024 | Scholar Rock Holding Corp | $SRRK | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A | Common Stock | 214285 | $0.00 | 364,285.0000 | 83,347,086 | 142.86% | 0.26% |
| Feb. 12, 2024 | Scholar Rock Holding Corp | $SRRK | Backstrom Jay T. | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 285715 | $0.00 | 285,715.0000 | 83,347,086 | 9999.99% | 0.34% |
| Dec. 29, 2022 | Disc Medicine, Inc. | $IRON | Backstrom Jay T. | Director | A | Stock Option (Right to Buy) | 7000 | $0.00 | 7,000.0000 | 0 | 9999.99% | 0.00% |